Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Cerulean Pharma Company Profile (NASDAQ:CERU)

Consensus Ratings for Cerulean Pharma (NASDAQ:CERU) (?)
Ratings Breakdown: 4 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $12.50 (144.14% upside)

Analysts' Ratings History for Cerulean Pharma (NASDAQ:CERU)
Show:
DateFirmActionRatingPrice TargetDetailsShare
5/6/2014Leerink SwannInitiated CoverageOutperform$13.00ViewTweet This Rating  Share This Rating on StockTwits
5/6/2014WedbushInitiated CoverageOutperform$12.00ViewTweet This Rating  Share This Rating on StockTwits
5/6/2014JMP SecuritiesInitiated CoverageOutperform$14.00ViewTweet This Rating  Share This Rating on StockTwits
5/6/2014Canaccord GenuityInitiated CoverageBuy$11.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 7/24/2012 forward)